{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T01:51:44Z","timestamp":1790819504629,"version":"4.1.0"},"reference-count":58,"publisher":"Oxford University Press (OUP)","issue":"2","funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,2,9]]},"DOI":"10.1093\/carcin\/bgx137","type":"journal-article","created":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T09:27:33Z","timestamp":1512120453000},"page":"242-251","source":"Crossref","is-referenced-by-count":68,"title":["CD38 knockout suppresses tumorigenesis in mice and clonogenic growth of human lung cancer cells"],"prefix":"10.1093","volume":"39","author":[{"given":"Xiangning","family":"Bu","sequence":"first","affiliation":[{"name":"Cardiovascular and Pulmonary Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiro","family":"Kato","sequence":"additional","affiliation":[{"name":"Cardiovascular and Pulmonary Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie A","family":"Hong","sequence":"additional","affiliation":[{"name":"Thoracic Epigenetics Section, Thoracic and GI Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria J","family":"Merino","sequence":"additional","affiliation":[{"name":"Translational Surgical Pathology, National Cancer Institute, Bethesda, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David S","family":"Schrump","sequence":"additional","affiliation":[{"name":"Thoracic Epigenetics Section, Thoracic and GI Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frances E","family":"Lund","sequence":"additional","affiliation":[{"name":"Department of Microbiology, University of Alabama at Birmingham, Birmingham, AL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel","family":"Moss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2017,12,8]]},"reference":[{"key":"key\n\t\t\t\t20180328140650_CIT0001","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3322\/caac.21262","article-title":"Global cancer statistics, 2012","volume":"65","author":"Torre","year":"2015","journal-title":"CA. Cancer J. Clin"},{"key":"key\n\t\t\t\t20180328140650_CIT0002","volume-title":"SEER Cancer Statistics Review, 1975\u20132013","author":"Howlader","year":"2016"},{"key":"key\n\t\t\t\t20180328140650_CIT0003","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1038\/nbt1137","article-title":"Monoclonal antibody therapy of cancer","volume":"23","author":"Adams","year":"2005","journal-title":"Nat. Biotechnol"},{"key":"key\n\t\t\t\t20180328140650_CIT0004","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1002\/ijc.29915","article-title":"Targeted therapies for treatment of non-small cell lung cancer\u2013Recent advances and future perspectives","volume":"138","author":"Minguet","year":"2016","journal-title":"Int. J. Cancer"},{"key":"key\n\t\t\t\t20180328140650_CIT0005","doi-asserted-by":"crossref","first-page":"12289","DOI":"10.18632\/oncotarget.6935","article-title":"ALK and ROS1 as targeted therapy paradigms and clinical implications to overcome crizotinib resistance","volume":"7","author":"Ye","year":"2016","journal-title":"Oncotarget"},{"key":"key\n\t\t\t\t20180328140650_CIT0006","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/j.ejca.2012.11.021","article-title":"Systemic therapy of advanced non-small cell lung cancer: major-developments of the last 5-years","volume":"49","author":"Cufer","year":"2013","journal-title":"Eur. J. Cancer"},{"key":"key\n\t\t\t\t20180328140650_CIT0007","first-page":"1023","article-title":"Quality of life of patients with lung cancer","volume":"9","author":"Polanski","year":"2016","journal-title":"Onco. Targets. Ther"},{"key":"key\n\t\t\t\t20180328140650_CIT0008","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1111\/cas.12941","article-title":"Gene aberrations for precision medicine against lung adenocarcinoma","volume":"107","author":"Saito","year":"2016","journal-title":"Cancer Sci"},{"key":"key\n\t\t\t\t20180328140650_CIT0009","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.jtho.2016.03.012","article-title":"Scientific advances in lung cancer 2015","volume":"11","author":"Tsao","year":"2016","journal-title":"J. Thorac. Oncol"},{"key":"key\n\t\t\t\t20180328140650_CIT0010","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s00726-010-0676-2","article-title":"ADP-ribosylation of arginine","volume":"41","author":"Laing","year":"2011","journal-title":"Amino Acids"},{"key":"key\n\t\t\t\t20180328140650_CIT0011","doi-asserted-by":"crossref","first-page":"5603","DOI":"10.1073\/pnas.82.17.5603","article-title":"Reversibility of arginine-specific mono(ADP-ribosyl)ation: identification in erythrocytes of an ADP-ribose-L-arginine cleavage enzyme","volume":"82","author":"Moss","year":"1985","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"key\n\t\t\t\t20180328140650_CIT0012","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S1054-3589(08)60277-X","article-title":"Mono-ADP-ribosylation: a reversible posttranslational modification of proteins","volume":"35","author":"Okazaki","year":"1996","journal-title":"Adv. Pharmacol"},{"key":"key\n\t\t\t\t20180328140650_CIT0013","doi-asserted-by":"crossref","first-page":"5534","DOI":"10.1128\/MCB.00302-07","article-title":"Enhanced sensitivity to cholera toxin in ADP-ribosylarginine hydrolase-deficient mice","volume":"27","author":"Kato","year":"2007","journal-title":"Mol. Cell. Biol"},{"key":"key\n\t\t\t\t20180328140650_CIT0014","doi-asserted-by":"crossref","first-page":"8231","DOI":"10.1073\/pnas.122238899","article-title":"ADP ribosylation of human neutrophil peptide-1 regulates its biological properties","volume":"99","author":"Paone","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"key\n\t\t\t\t20180328140650_CIT0015","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S1074-7613(03)00266-8","article-title":"NAD-induced T cell death: ADP-ribosylation of cell surface proteins by ART2 activates the cytolytic P2X7 purinoceptor","volume":"19","author":"Seman","year":"2003","journal-title":"Immunity"},{"key":"key\n\t\t\t\t20180328140650_CIT0016","doi-asserted-by":"crossref","first-page":"e151","DOI":"10.1038\/oncsis.2015.5","article-title":"Mutations of the functional ARH1 allele in tumors from ARH1 heterozygous mice and cells affect ARH1 catalytic activity, cell proliferation and tumorigenesis","volume":"4","author":"Kato","year":"2015","journal-title":"Oncogenesis"},{"key":"key\n\t\t\t\t20180328140650_CIT0017","doi-asserted-by":"crossref","first-page":"5327","DOI":"10.1158\/0008-5472.CAN-10-0733","article-title":"ADP-ribosylarginine hydrolase regulates cell proliferation and tumorigenesis","volume":"71","author":"Kato","year":"2011","journal-title":"Cancer Res"},{"key":"key\n\t\t\t\t20180328140650_CIT0018","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/cyto.b.21092","article-title":"CD38 and CD157: a long journey from activation markers to multifunctional molecules","volume":"84","author":"Quarona","year":"2013","journal-title":"Cytometry B. Clin. Cytom"},{"key":"key\n\t\t\t\t20180328140650_CIT0019","doi-asserted-by":"crossref","first-page":"249","DOI":"10.2174\/1566524043360708","article-title":"Structure and enzymology of ADP-ribosyl cyclases: conserved enzymes that produce multiple calcium mobilizing metabolites","volume":"4","author":"Schuber","year":"2004","journal-title":"Curr. Mol. Med"},{"key":"key\n\t\t\t\t20180328140650_CIT0020","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1126\/science.8235624","article-title":"Formation and hydrolysis of cyclic ADP-ribose catalyzed by lymphocyte antigen CD38","volume":"262","author":"Howard","year":"1993","journal-title":"Science"},{"key":"key\n\t\t\t\t20180328140650_CIT0021","doi-asserted-by":"crossref","first-page":"30327","DOI":"10.1074\/jbc.270.51.30327","article-title":"ADP-ribosyl cyclase and CD38 catalyze the synthesis of a calcium-mobilizing metabolite from NADP","volume":"270","author":"Aarhus","year":"1995","journal-title":"J. Biol. Chem"},{"key":"key\n\t\t\t\t20180328140650_CIT0022","doi-asserted-by":"crossref","first-page":"2693","DOI":"10.4049\/jimmunol.162.5.2693","article-title":"CD38 signaling in B lymphocytes is controlled by its ectodomain but occurs independently of enzymatically generated ADP-ribose or cyclic ADP-ribose","volume":"162","author":"Lund","year":"1999","journal-title":"J. Immunol"},{"key":"key\n\t\t\t\t20180328140650_CIT0023","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1006\/bbrc.1994.2326","article-title":"Cell surface antigen CD38 identified as ecto-enzyme of NAD glycohydrolase has hyaluronate-binding activity","volume":"203","author":"Nishina","year":"1994","journal-title":"Biochem. Biophys. Res. Commun"},{"key":"key\n\t\t\t\t20180328140650_CIT0024","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1172\/JCI5928","article-title":"Switched at birth: a new family for PECAM-1","volume":"103","author":"Newman","year":"1999","journal-title":"J. Clin. Invest"},{"key":"key\n\t\t\t\t20180328140650_CIT0025","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1152\/physrev.00035.2007","article-title":"Evolution and function of the ADP ribosyl cyclase\/CD38 gene family in physiology and pathology","volume":"88","author":"Malavasi","year":"2008","journal-title":"Physiol. Rev"},{"key":"key\n\t\t\t\t20180328140650_CIT0026","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1182\/blood-2003-03-0989","article-title":"CD38 is a signaling molecule in B-cell chronic lymphocytic leukemia cells","volume":"102","author":"Deaglio","year":"2003","journal-title":"Blood"},{"key":"key\n\t\t\t\t20180328140650_CIT0027","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1309\/74R4TB90BUWH27JX","article-title":"Flow cytometric immunophenotypic analysis of 306 cases of multiple myeloma","volume":"121","author":"Lin","year":"2004","journal-title":"Am. J. Clin. Pathol"},{"key":"key\n\t\t\t\t20180328140650_CIT0028","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1517\/13543784.2014.889681","article-title":"Daratumumab granted breakthrough drug status","volume":"23","author":"Laubach","year":"2014","journal-title":"Expert Opin. Investig. Drugs"},{"key":"key\n\t\t\t\t20180328140650_CIT0029","first-page":"1746","article-title":"Retinoic acid-induced expression of CD38 antigen in myeloid cells is mediated through retinoic acid receptor-alpha","volume":"54","author":"Drach","year":"1994","journal-title":"Cancer Res"},{"key":"key\n\t\t\t\t20180328140650_CIT0030","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.leukres.2006.07.004","article-title":"Retinoic acid-induced CD38 antigen promotes leukemia cells attachment and interferon-gamma\/interleukin-1beta-dependent apoptosis of endothelial cells: implications in the etiology of retinoic acid syndrome","volume":"31","author":"Gao","year":"2007","journal-title":"Leuk. Res"},{"key":"key\n\t\t\t\t20180328140650_CIT0031","doi-asserted-by":"crossref","first-page":"3470","DOI":"10.1182\/blood-2011-06-275610","article-title":"CD38 and chronic lymphocytic leukemia: a decade later","volume":"118","author":"Malavasi","year":"2011","journal-title":"Blood"},{"key":"key\n\t\t\t\t20180328140650_CIT0032","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/leu.2014.207","article-title":"The enzymatic activities of CD38 enhance CLL growth and trafficking: implications for therapeutic targeting","volume":"29","author":"Vaisitti","year":"2015","journal-title":"Leukemia"},{"key":"key\n\t\t\t\t20180328140650_CIT0033","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1172\/JCI64264","article-title":"Mitochondrial complex I activity and NAD+\/NADH balance regulate breast cancer progression","volume":"123","author":"Santidrian","year":"2013","journal-title":"J. Clin. Invest"},{"key":"key\n\t\t\t\t20180328140650_CIT0034","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1182\/blood.V92.4.1324","article-title":"Mice deficient for the ecto-nicotinamide adenine dinucleotide glycohydrolase CD38 exhibit altered humoral immune responses","volume":"92","author":"Cockayne","year":"1998","journal-title":"Blood"},{"key":"key\n\t\t\t\t20180328140650_CIT0035","doi-asserted-by":"crossref","first-page":"912","DOI":"10.3892\/ol.2016.5512","article-title":"Reproducibility of the EGFR immunohistochemistry scores for tumor samples from patients with advanced non-small cell lung cancer","volume":"13","author":"Avil\u00e9s-Salas","year":"2017","journal-title":"Oncol. Lett"},{"key":"key\n\t\t\t\t20180328140650_CIT0036","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.bbrc.2006.05.100","article-title":"Decreased cADPR and increased NAD+ in the Cd38-\/- mouse","volume":"346","author":"Young","year":"2006","journal-title":"Biochem. Biophys. Res. Commun"},{"key":"key\n\t\t\t\t20180328140650_CIT0037","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1476-5586(04)80047-2","article-title":"ONCOMINE: a cancer microarray database and integrated data-mining platform","volume":"6","author":"Rhodes","year":"2004","journal-title":"Neoplasia"},{"key":"key\n\t\t\t\t20180328140650_CIT0038","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1182\/blood-2005-08-3182","article-title":"CXCR4: a key receptor in the crosstalk between tumor cells and their microenvironment","volume":"107","author":"Burger","year":"2006","journal-title":"Blood"},{"key":"key\n\t\t\t\t20180328140650_CIT0039","doi-asserted-by":"crossref","first-page":"4012","DOI":"10.1182\/blood-2007-06-094029","article-title":"CD38 and ZAP-70 are functionally linked and mark CLL cells with high migratory potential","volume":"110","author":"Deaglio","year":"2007","journal-title":"Blood"},{"key":"key\n\t\t\t\t20180328140650_CIT0040","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1038\/leu.2010.36","article-title":"CD38 increases CXCL12-mediated signals and homing of chronic lymphocytic leukemia cells","volume":"24","author":"Vaisitti","year":"2010","journal-title":"Leukemia"},{"key":"key\n\t\t\t\t20180328140650_CIT0041","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1093\/neuonc\/nos121","article-title":"CD38 deficiency in the tumor microenvironment attenuates glioma progression and modulates features of tumor-associated microglia\/macrophages","volume":"14","author":"Levy","year":"2012","journal-title":"Neuro. Oncol"},{"key":"key\n\t\t\t\t20180328140650_CIT0042","article-title":"CD38 enhances the proliferation and inhibits the apoptosis of cervical cancer cells by affecting the mitochondria functions","author":"Liao","year":"2017","journal-title":"Mol Carcinog., 56, 2245\u20132257"},{"key":"key\n\t\t\t\t20180328140650_CIT0043","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.pharmthera.2016.12.002","article-title":"CD38 in the pathogenesis of allergic airway disease: Potential therapeutic targets","volume":"172","author":"Deshpande","year":"2017","journal-title":"Pharmacol. Ther"},{"key":"key\n\t\t\t\t20180328140650_CIT0044","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1084\/jem.20071267","article-title":"Identification of an alternative G{alpha}q-dependent chemokine receptor signal transduction pathway in dendritic cells and granulocytes","volume":"204","author":"Shi","year":"2007","journal-title":"J. Exp. Med"},{"key":"key\n\t\t\t\t20180328140650_CIT0045","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1038\/nm1101-1209","article-title":"Cyclic ADP-ribose production by CD38 regulates intracellular calcium release, extracellular calcium influx and chemotaxis in neutrophils and is required for bacterial clearance in vivo","volume":"7","author":"Partida-S\u00e1nchez","year":"2001","journal-title":"Nat. Med"},{"key":"key\n\t\t\t\t20180328140650_CIT0046","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1126\/science.aad5168","article-title":"Biosensor reveals multiple sources for mitochondrial NAD\u207a","volume":"352","author":"Cambronne","year":"2016","journal-title":"Science"},{"key":"key\n\t\t\t\t20180328140650_CIT0047","article-title":"Cytosolic interaction of type III human CD38 with CIB1 modulates cellular cyclic ADP-ribose levels","author":"Liu","year":"2017","journal-title":"Proc Natl Acad Sci USA, 114, 8283\u20138288"},{"key":"key\n\t\t\t\t20180328140650_CIT0048","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/j.cmet.2016.05.006","article-title":"CD38 Dictates Age-Related NAD Decline and Mitochondrial Dysfunction through an SIRT3-Dependent Mechanism","volume":"23","author":"Camacho-Pereira","year":"2016","journal-title":"Cell Metab"},{"key":"key\n\t\t\t\t20180328140650_CIT0049","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1038\/nrc3985","article-title":"The multifaceted functions of sirtuins in cancer","volume":"15","author":"Chalkiadaki","year":"2015","journal-title":"Nat. Rev. Cancer"},{"key":"key\n\t\t\t\t20180328140650_CIT0050","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/imr.12389","article-title":"Monoclonal antibodies targeting CD38 in hematological malignancies and beyond","volume":"270","author":"van de Donk","year":"2016","journal-title":"Immunol Rev"},{"key":"key\n\t\t\t\t20180328140650_CIT0051","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1182\/blood.V94.6.1840","article-title":"Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia","volume":"94","author":"Damle","year":"1999","journal-title":"Blood"},{"key":"key\n\t\t\t\t20180328140650_CIT0052","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/sj.leu.2402339","article-title":"CD38 expression is an important prognostic marker in chronic lymphocytic leukaemia","volume":"16","author":"D\u00fcrig","year":"2002","journal-title":"Leukemia"},{"key":"key\n\t\t\t\t20180328140650_CIT0053","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1046\/j.0007-1048.2001.3205.x","article-title":"CD38 expression and secondary 17p deletion are important prognostic factors in chronic lymphocytic leukaemia","volume":"116","author":"Chevallier","year":"2002","journal-title":"Br. J. Haematol"},{"key":"key\n\t\t\t\t20180328140650_CIT0054","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1007\/s00277-015-2359-2","article-title":"CD38 expression predicts poor prognosis and might be a potential therapy target in extranodal NK\/T cell lymphoma, nasal type","volume":"94","author":"Wang","year":"2015","journal-title":"Ann. Hematol"},{"key":"key\n\t\t\t\t20180328140650_CIT0055","doi-asserted-by":"crossref","first-page":"4074","DOI":"10.1158\/0008-5472.CAN-14-3639","article-title":"CD38-expressing myeloid-derived suppressor cells promote tumor growth in a murine model of esophageal cancer","volume":"75","author":"Karakasheva","year":"2015","journal-title":"Cancer Res"},{"key":"key\n\t\t\t\t20180328140650_CIT0056","doi-asserted-by":"crossref","first-page":"e17359","DOI":"10.1371\/journal.pone.0017359","article-title":"The PI3K p110\u03b4 regulates expression of CD38 on regulatory T cells","volume":"6","author":"Patton","year":"2011","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20180328140650_CIT0057","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.4049\/jimmunol.1301317","article-title":"Tumor-infiltrating regulatory T cells inhibit endogenous cytotoxic T cell responses to lung adenocarcinoma","volume":"191","author":"Ganesan","year":"2013","journal-title":"J. Immunol"},{"key":"key\n\t\t\t\t20180328140650_CIT0058","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s40265-015-0536-1","article-title":"Daratumumab: first global approval","volume":"76","author":"McKeage","year":"2016","journal-title":"Drugs"}],"container-title":["Carcinogenesis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/carcin\/article-pdf\/39\/2\/242\/24347231\/bgx137.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,29]],"date-time":"2023-08-29T11:42:52Z","timestamp":1693309372000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/carcin\/article\/39\/2\/242\/4712089"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,8]]},"references-count":58,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2017,12,8]]},"published-print":{"date-parts":[[2018,2,9]]}},"URL":"https:\/\/doi.org\/10.1093\/carcin\/bgx137","relation":{},"ISSN":["0143-3334","1460-2180"],"issn-type":[{"value":"0143-3334","type":"print"},{"value":"1460-2180","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,2]]},"published":{"date-parts":[[2017,12,8]]}}}